Cargando…
Apolipoproteins—New Biomarkers of Overweight and Obesity among Childhood Acute Lymphoblastic Leukemia Survivors?
Patients suffering from childhood acute lymphoblastic leukemia (ALL) are at risk of late adverse treatment-related effects. The examination of targeted biomarkers could be used to improve the diagnosis and prediction of life-threatening ALL sequelae. The purpose of this cross-sectional study was to...
Autores principales: | Sztolsztener, Klaudia, Żywno, Hubert, Hodun, Katarzyna, Konończuk, Katarzyna, Muszyńska-Rosłan, Katarzyna, Latoch, Eryk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505294/ https://www.ncbi.nlm.nih.gov/pubmed/36142534 http://dx.doi.org/10.3390/ijms231810634 |
Ejemplares similares
-
Asymptomatic Survivors of Childhood Acute Lymphoblastic Leukemia Demonstrate a Biological Profile of Inflamm-Aging Early in Life
por: Latoch, Eryk, et al.
Publicado: (2022) -
Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia
por: Konończuk, Katarzyna, et al.
Publicado: (2022) -
Increased Levels of Adipocyte and Epidermal Fatty Acid-Binding Proteins in Acute Lymphoblastic Leukemia Survivors
por: Konończuk, Katarzyna, et al.
Publicado: (2021) -
Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors
por: Latoch, Eryk, et al.
Publicado: (2020) -
Urinary Beta-2-Microglobulin and Late Nephrotoxicity in Childhood Cancer Survivors
por: Latoch, Eryk, et al.
Publicado: (2021)